Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-13-041632)

Filing Details

Accession Number:: 0001181431-13-041632
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-07-29 13:34:58
Reporting Period:: 2013-07-26

Filing Date:: 2013-07-29
Accepted Time:: 2013-07-29 13:34:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1533040	Rxi Pharmaceuticals Corp	RXII	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1285648	Geert Cauwenbergh	C/O Rxi Pharmaceuticals Corporation 1500 West Park Drive, Suite 210 Westborough MA 01581	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Acquisiton	2013-07-26	500	$4.87	8,833	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Effective at July 23, 2013 at 11:59 p.m., Eastern time, the Issuer effected a reverse split of its outstanding shares of common stock at a ratio of 30-for-1.